A phase II study of insulin-like growth factor receptor inhibition with nordihydroguaiaretic acid in men with non-metastatic hormone-sensitive prostate cancer

Author:                    

Publisher: Spandidos Publications

ISSN: 1021-335X

Source: Oncology Reports, Vol.27, Iss.1, 2012-01, pp. : 3-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content